The study evaluated the efficacy and safety of Dovato in 230 antiretroviral treatment-naïve individuals with advanced HIV.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

Antiretroviral therapies work to help stop replication of the HIV virus in the body and can reduce the viral load to a point ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant’s baseline viral load. These data were presented at HIV Glasgow 2024, being held in ...

Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection ...

At eight weeks, the viral load of HIV declined in all participants and death of the infected cells was observed. Due to ...

Gilead Sciences, Inc. today announced the presentation of new research data from its innovative HIV treatment portfolio and pipeline, including a broad range of data on investigational and marketed ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...